Philip Van Kerrebroeck
Overview
Explore the profile of Philip Van Kerrebroeck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
4750
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Denkinger M, Knol W, Cherubini A, Simonds A, Lionis C, Lacombe D, et al.
Lancet Healthy Longev
. 2023 Nov;
4(12):e724-e729.
PMID: 37977177
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E7, the guidance for the conduct of clinical trials in people older than age 65 years,...
2.
Van Kerrebroeck P
Acta Chir Belg
. 2023 Aug;
124(3):187-190.
PMID: 37606055
Background: Urology as a separate surgical specialty is a nineteenth century European development. The background of the origins of this new specialty and the elements that were responsible for it...
3.
Te Dorsthorst M, Digesu A, Van Kerrebroeck P, Elneil S, van Breda J, Janssen D, et al.
Neurourol Urodyn
. 2022 Jan;
41(2):679-684.
PMID: 35019163
Purpose: The aim of this study was to demonstrate features predictive of treatment response for patient-tailored overactive bladder (OAB) intervention with an implantable tibial neurostimulator using patient and technical prediction...
4.
Dudding T, Lehur P, Sorensen M, Engelberg S, Bertapelle M, Chartier-Kastler E, et al.
Neuromodulation
. 2021 Jul;
24(7):1247-1257.
PMID: 34264542
Objectives: In some patients treated for urinary or fecal incontinence with sacral neuromodulation (SNM) persistence of symptoms, a reduction in efficacy or adverse effects of stimulation can occur. In such...
5.
Jairam R, Drossaerts J, Marcelissen T, Van Koeveringe G, Vrijens D, Van Kerrebroeck P
Urol Int
. 2021 May;
106(4):323-343.
PMID: 34058731
Introduction: Sacral neuromodulation (SNM) is an effective treatment in patients with overactive bladder syndrome or nonobstructive urinary retention when conservative treatment fails. Several factors that could impact outcome with SNM...
6.
Pezzella A, McCrery R, Lane F, Benson K, Taylor C, Padron O, et al.
Neurourol Urodyn
. 2021 Jan;
40(2):714-721.
PMID: 33508155
Aims: Sacral neuromodulation (SNM) is a guideline-recommended treatment with proven therapeutic benefit for urinary urgency incontinence (UUI) patients. The Axonics® System is the first Food and Drug Administration-approved rechargeable SNM...
7.
Benson K, McCrery R, Taylor C, Padron O, Blok B, De Wachter S, et al.
Neurourol Urodyn
. 2020 Apr;
39(5):1482-1488.
PMID: 32339339
Aims: Sacral neuromodulation (SNM) is a guideline-recommended treatment for voiding dysfunction including urgency, urge incontinence, and nonobstructive retention as well as fecal incontinence. The Axonics® System is a miniaturized, rechargeable...
8.
Blok B, Van Kerrebroeck P, de Wachter S, Ruffion A, Van der Aa F, Perrouin-Verbe M, et al.
Neurourol Urodyn
. 2020 Apr;
39(4):1108-1114.
PMID: 32243625
Aims: Sacral neuromodulation (SNM) therapy for overactive bladder (OAB) has proven long-term safety and efficacy. Historically, the only commercially available SNM device was nonrechargeable requiring replacement surgery due to battery...
9.
McCrery R, Lane F, Benson K, Taylor C, Padron O, Blok B, et al.
J Urol
. 2019 Oct;
203(1):192.
PMID: 31580190
No abstract available.
10.
McCrery R, Lane F, Benson K, Taylor C, Padron O, Blok B, et al.
J Urol
. 2019 Jul;
203(1):185-192.
PMID: 31347955
Purpose: Sacral neuromodulation is a guideline recommended treatment of urinary dysfunction and fecal incontinence in patients in whom conservative treatments have failed. Historically sacral neuromodulation has been delivered using a...